Dss's impact biomedical provides updates on key research projects and global licensing opportunities

Rochester, n.y., july 06, 2021 (globe newswire) -- impact biomedical inc., a wholly owned subsidiary of document security systems inc. (nyse american: dss), today announced updates to several of its key research projects, including key collaborations, breakthroughs in treatment protocols and potential global licensing opportunities as a way to begin planning the next phase of its research agenda and position itself as a global leader in the future of biotech.
DSS Ratings Summary
DSS Quant Ranking